Thrombin trivalent inhibitors inspired by native peptidic inhibitors from hematophagous arthropods Feb. 8, 2021 No Comments
Xarelto approved in Japan to treat children with VTE and to prevent VTE recurrence Jan. 26, 2021 No Comments
Incyte initiates phase I/II study of INCB-000928 in patients with anemia due to MF Jan. 26, 2021 No Comments
Orladeyo approved in Japan for the prophylactic treatment of hereditary angioedema Jan. 25, 2021 No Comments
European Commission approves extension of the indication for Doptelet as treatment of ITP Jan. 21, 2021 No Comments
Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present factor XIa inhibitors Jan. 20, 2021 No Comments
EdiGene obtains IND approval in China for ET-01 for transfusion dependent beta-thalassemia Jan. 18, 2021 No Comments
Promising data presented from global phase III study with valoctocogene roxaparvovec in hemophilia A Jan. 12, 2021 No Comments